WO1995011659A3 - Pharmaceutical preparation with immuno-correcting properties based on a cell suspension, and a method of treating sugar diabetes using said preparation - Google Patents

Pharmaceutical preparation with immuno-correcting properties based on a cell suspension, and a method of treating sugar diabetes using said preparation Download PDF

Info

Publication number
WO1995011659A3
WO1995011659A3 PCT/UA1994/000025 UA9400025W WO9511659A3 WO 1995011659 A3 WO1995011659 A3 WO 1995011659A3 UA 9400025 W UA9400025 W UA 9400025W WO 9511659 A3 WO9511659 A3 WO 9511659A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
pharmaceutical preparation
cell suspension
immuno
treating sugar
Prior art date
Application number
PCT/UA1994/000025
Other languages
French (fr)
Russian (ru)
Other versions
WO1995011659A2 (en
Inventor
Andrei Semenovich Efimov
Alexandr Ivanovich Smikodub
Kaya Alla Vladimirovna Novits
Original Assignee
Ts Embrionalnych Tkanei Emcell
Andrei Semenovich Efimov
Alexandr Ivanovich Smikodub
Kaya Alla Vladimirovna Novits
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ts Embrionalnych Tkanei Emcell, Andrei Semenovich Efimov, Alexandr Ivanovich Smikodub, Kaya Alla Vladimirovna Novits filed Critical Ts Embrionalnych Tkanei Emcell
Priority to NL9420012A priority Critical patent/NL194693C/en
Publication of WO1995011659A2 publication Critical patent/WO1995011659A2/en
Publication of WO1995011659A3 publication Critical patent/WO1995011659A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes

Abstract

The invention relates to medicine, in particular cell therapy. A patent is sought for a pharmaceutical preparation characterized by a specific composition and quantitative indicators of a cell suspension obtained from native or cryogenically preserved haemopoietic tissue from a human embryo liver and/or spleen. In addition, a patent is sought for a method of treating sugar diabetes involving the introduction of the said pharmaceutical preparation, which is selected in the light of the patient's individual indicators from a specially created tissue bank containing a variety of samples, the same sample being used for a subsequent application.
PCT/UA1994/000025 1993-10-18 1994-10-17 Pharmaceutical preparation with immuno-correcting properties based on a cell suspension, and a method of treating sugar diabetes using said preparation WO1995011659A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NL9420012A NL194693C (en) 1993-10-18 1994-10-17 Method for the preparation of medicinal preparations for treating diabetes.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
UA94020324A UA27048C2 (en) 1993-10-18 1993-10-18 Medicinal preparation of immunoreplacement activity the basis of cellular suspension and method for treatment of diabetes mellitus by the use of this preparation
UA94020324 1993-10-18

Publications (2)

Publication Number Publication Date
WO1995011659A2 WO1995011659A2 (en) 1995-05-04
WO1995011659A3 true WO1995011659A3 (en) 1995-06-01

Family

ID=21688946

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/UA1994/000025 WO1995011659A2 (en) 1993-10-18 1994-10-17 Pharmaceutical preparation with immuno-correcting properties based on a cell suspension, and a method of treating sugar diabetes using said preparation

Country Status (5)

Country Link
CA (1) CA2152078A1 (en)
NL (1) NL194693C (en)
RU (1) RU2126260C1 (en)
UA (1) UA27048C2 (en)
WO (1) WO1995011659A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000035464A1 (en) * 1998-12-16 2000-06-22 Tsentr Embrionalnykh Tkanei 'emcell' Method for treating patients using cellular suspensions of embryonic tissues
RU2160112C1 (en) * 2000-04-10 2000-12-10 Сухих Геннадий Тихонович Method for producing cellular transplant from fetus tissues
RU2007112288A (en) * 2007-04-03 2008-10-10 Александр Сергеевич Ботин (RU) COMPOSITION FOR STIMULATING GROWTH AND REGENERATION OF CELLS, AND ALSO WAY OF ITS PRODUCTION

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254103A (en) * 1979-06-08 1981-03-03 Institul de Cercetari Chimicofarmaceutice Hepatoprotector Factor (HF) and method of treatment
GB1592637A (en) * 1978-03-22 1981-07-08 Parmer L P Lipid extract for inhibiting platelet function in blood
SU1158201A1 (en) * 1983-06-03 1985-05-30 Ленинградское Ордена Ленина,Ордена Трудового Красного Знамени Производственное Объединение Мясной Промышленности Им.С.М.Кирова Method of obtaining stimulator from mammalia spleen
SU1367837A3 (en) * 1980-01-15 1988-01-15 Рихтер Гедеон Ведьесети Дьяр Рт (Инопредприятие) Method of producing agent selectively inhibiting growth or reproduction of normal and leukemia cells of myeloids
EP0357958A2 (en) * 1988-08-04 1990-03-14 Schwarz Pharma Ag Pharmaceutical preparation against viral diseases comprising a liver extract
WO1992010197A1 (en) * 1990-12-11 1992-06-25 Zetesis S.P.A. Substances of polypeptide nature useful in human therapy

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1592637A (en) * 1978-03-22 1981-07-08 Parmer L P Lipid extract for inhibiting platelet function in blood
US4254103A (en) * 1979-06-08 1981-03-03 Institul de Cercetari Chimicofarmaceutice Hepatoprotector Factor (HF) and method of treatment
SU1367837A3 (en) * 1980-01-15 1988-01-15 Рихтер Гедеон Ведьесети Дьяр Рт (Инопредприятие) Method of producing agent selectively inhibiting growth or reproduction of normal and leukemia cells of myeloids
SU1158201A1 (en) * 1983-06-03 1985-05-30 Ленинградское Ордена Ленина,Ордена Трудового Красного Знамени Производственное Объединение Мясной Промышленности Им.С.М.Кирова Method of obtaining stimulator from mammalia spleen
EP0357958A2 (en) * 1988-08-04 1990-03-14 Schwarz Pharma Ag Pharmaceutical preparation against viral diseases comprising a liver extract
WO1992010197A1 (en) * 1990-12-11 1992-06-25 Zetesis S.P.A. Substances of polypeptide nature useful in human therapy

Also Published As

Publication number Publication date
NL9420012A (en) 1995-12-01
NL194693B (en) 2002-08-01
NL194693C (en) 2002-12-03
WO1995011659A2 (en) 1995-05-04
CA2152078A1 (en) 1995-05-27
RU2126260C1 (en) 1999-02-20
UA27048C2 (en) 2000-02-28

Similar Documents

Publication Publication Date Title
Ghalayini et al. Phosphatidylinositol 4, 5-bisphosphate: light-mediated breakdown in the vertebrate retina
Watson The extracellular nature of enamel in the rat
DE69839326T2 (en) COMPOSITIONS AND METHODS FOR MODULATING THE CELLULAR ACTIVITY OF NF-kappaB
EP0021152B1 (en) Process for the immunological determination of basement membrane material, specific basement membrane fragments therefor and process for preparing or winning them
UA27874C2 (en) HUMAN INSULIN DRUG, METHOD OF PREPARATION OF THE DRUG, METHOD OF TREATMENT OF DIABETES MELLITUS
CA2203885A1 (en) Treating red blood cell solutions with anti-viral agents
ZA958444B (en) Biological active proteins
WO2001000828A3 (en) Compositions and methods for the therapy and diagnosis of lung cancer
WO2000060076A3 (en) Compositions for the treatment and diagnosis of breast cancer and methods for their use
WO2001040269A3 (en) Compositions and methods for therapy and diagnosis of breast cancer
WO2000060077A3 (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
ATE17858T1 (en) ANGIOTROPINS FROM WLEUCCYTES AND INFLAMMATED TISSUES: A NEW CLASS OF NATURAL CHEMOTROPIC AND MITOGENIC PROTEINS FOR THE SPECIFIC INDUCTION OF REGULATED GROWTH OF BLOOD VESSELS, FOR NEW ANGELIZATION OF TISSUES AND FOR THE MORPHOGENESIS OF BLOOD VESSEL BRANCHING; PROCESSES FOR THEIR BIOTECHNICAL PRODUCTION AND PHARMACEUTICAL COMPOSITIONS.
WO2002057795A3 (en) Methods of diagnosis and treatment of osteoporosis
EP1715043A3 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
DE4221836A1 (en) New mistletoe lectin - with immunomodulatory activity, useful for cancer adjuvant therapy
Tsunekawa et al. Calpain proteolysis of free and bound forms of calponin, a troponin T‐like protein in smooth muscle
WO1995011659A3 (en) Pharmaceutical preparation with immuno-correcting properties based on a cell suspension, and a method of treating sugar diabetes using said preparation
Keyser Science and magic in Galen’s recipes (Sympathy and efficacy)
WO2000078960A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer
Bruze et al. Contact allergy to dichlorinated methylisothiazolinone.
Hanin et al. Acetylcholine and choline in human plasma and red blood cells: a gas chromatograph mass spectrometric evaluation
Baptista et al. Plastination of the wrist: Potential uses in education and clinical medicine
CN109369784B (en) PaTx-1 toxin and its application
RU95120165A (en) DRUG IMMUNE SUBSTITUTING ACTION ON THE BASIS OF CELLULAR SUSPENSION AND METHOD FOR TREATMENT OF THE ACQUIRED IMMUNODEFICIENCY SYNDROME (HIV INFECTION) USING THIS ANTID
Kellermann Further studies on the AB0-typing of ancient bones

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA ES NL RU US

AK Designated states

Kind code of ref document: A3

Designated state(s): CA ES NL RU US

ENP Entry into the national phase

Ref document number: 9550021

Country of ref document: ES

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 009550021

Country of ref document: ES

Ref document number: P009550021

Country of ref document: ES

WWE Wipo information: entry into national phase

Ref document number: 2152078

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 1995 481478

Country of ref document: US

Date of ref document: 19950915

Kind code of ref document: A

WWR Wipo information: refused in national office

Ref document number: 9550021

Country of ref document: ES

Kind code of ref document: A